Invasive meningococcal disease in Québec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19)

52Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

During periods of endemic meningococcal disease, serogroup B Neisseria meningitidis is responsible for a significant percentage of invasive diseases, and no particular clone or strain predominates (F. E. Ashton and D. A. Caugant, Can. J. Microbiol. 47: 293-289, 2001), However, in the winter of 2004 to 2005, a cluster of serogroup B meningococcal disease occurred in one region in the province of Québec, Canada. The N. meningitidis strain responsible for this cluster of cases was identified as sequence type ST-269 with the antigenic formula B:17:P1.19. Retrospective analysis of isolates from 2000 onwards showed that this clone first emerged in the province of Québec in 2003. The emergence of this clone of serogroup B meningococci occurred after a mass vaccination against serogroup C N. meningitidis, suggesting possible capsule replacement. Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Law, D. K. S., Lorange, M., Ringuette, L., Dion, R., Giguère, M., Henderson, A. M., … Tsang, R. S. W. (2006). Invasive meningococcal disease in Québec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). Journal of Clinical Microbiology, 44(8), 2743–2749. https://doi.org/10.1128/JCM.00601-06

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free